Boston Bio Systems Financials

BSE: 531458

₹5.20

₹0.41 (8.56%)

As on 03-Sep-2026IST

Market cap

₹4 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

-2.9

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	0.48	0.19	--	--	--	--
Total Income	0.48	0.19	--	--	--	--
Total Expenditure	7.07	0.74	0.14	0.00	0.00	0.00
EBITDA	-6.58	-0.55	-0.14	0.00	0.00	0.00
Depreciation	--	--	--	--	--	--
EBIT	-6.58	-0.55	-0.14	0.00	0.00	0.00
Interest	0.59	--	--	--	--	--
Other Income	--	--	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-7.18	-0.55	-0.14	0.00	0.00	0.00
Provision for Tax	--	--	--	--	--	--
Profit after Tax	-7.18	-0.55	-0.14	0.00	0.00	0.00

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	-1.27	5.90	6.45	6.59	6.59	6.60
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	4.59	0.12	0.12	0.12	0.12
Current Liabilities	2.04	4.41	4.00	3.86	3.86	3.86
Total Liabilities	0.77	14.90	10.57	10.57	10.57	10.57

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	--	5.79	5.79	5.79	5.79	5.79
Current Assets	0.77	9.11	4.77	4.77	4.78	4.78
Total Assets	0.77	14.90	10.57	10.57	10.57	10.57
Total Debt*	--	5.44	0.87	0.87	0.87	0.87
Net Current Assets	-1.27	4.70	0.77	0.91	0.92	0.92
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	--	-4.59	--	0.00	0.00	0.00
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	4.58	--	--	--	--
Net Cash Inflow / Outflow	--	-0.01	--	0.00	0.00	0.00

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	-10.25	-0.78	-0.20	0.00	0.00	0.00
Cash EPS (₹)	-10.25	-0.78	-0.20	0.00	0.00	0.00
Adjusted Book Value (₹)	-1.82	8.43	9.21	9.41	9.42	9.42
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-6.55	--	0.00	0.00	0.00
Free Cash Flow per Share (₹)	--	-6.55	--	0.00	0.00	0.00

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	--	-5.86	-1.90	-0.03	-0.03	-0.03
ROE (%)	--	-8.86	-2.16	-0.03	-0.03	-0.03
ROA (%)	-91.57	-4.30	-1.33	-0.02	-0.02	-0.02
EBIT Margin (%)	-1,360.33	-284.31	--	--	--	--
Net Margin (%)	-1,482.64	-284.31	--	--	--	--
Cash Profit Margin (%)	--	-284.31	--	--	--	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	152.08	--	--	--	--	--
EBIT Growth (%)	--	-288.98	-6,295.45	-17.02	3.59	-33.60
Net Profit Growth (%)	-1,209.49	-288.98	-6,295.45	-17.02	3.59	-29.65
EPS Growth (%)	-1,209.55	-289.05	-6,380.65	-14.81	3.57	-33.33
Book Value Growth (%)	--	-8.48	-2.13	-0.03	-0.03	-0.03

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	-0.51	--	--	--	--	--
Price / Book Value	-2.86	1.92	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.79	-30.58	-55.55	-3,552.59	-4,156.60	-4,006.94
Close Price (₹)	7.88	16.19	--	--	--	--
High Price (₹)	15.39	22.00	--	--	--	--
Low Price (₹)	5.13	16.19	--	--	--	--
Market Cap (₹ Cr)	3.64	11.34	--	--	--	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	--	0.92	0.13	0.13	0.13	0.13
Short term debt to equity ratio	--	0.14	0.12	0.11	0.11	0.11
Current Ratio	0.38	2.07	1.19	1.24	1.24	1.24
Quick Ratio	0.38	2.03	1.16	1.20	1.20	1.20
Interest Coverage	-11.12	--	--	--	--	--

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	--	1,495.27	--	--	--	--
Asset Turnover	0.06	0.02	--	--	--	--
Receivable days	--	5,457.75	--	--	--	--
Inventory Days	--	274.56	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.